ecabapide has been researched along with nitroarginine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuhama, K; Hatanaka, S; Niijima, A | 1 |
| Suzuki, H; Takano, H | 1 |
2 other study(ies) available for ecabapide and nitroarginine
| Article | Year |
|---|---|
Possible mechanisms underlying the suppression of gastric vagal afferents due to ecabapide (DQ-2511), a gastroprokinetic agent, in rats.
Topics: Animals; Anti-Ulcer Agents; Benzamides; Cyclic GMP; Depression, Chemical; Enzyme Inhibitors; Gastrointestinal Motility; Male; Neurons, Afferent; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Rats; Rats, Wistar; Stomach; Vagus Nerve | 1997 |
Junctional transmissions in smooth muscle of the guinea pig duodenum and their modulation by the prokinetic agent DQ-2511.
Topics: Analgesics; Animals; Anti-Ulcer Agents; Apamin; Atropine; Autonomic Agents; Benzamides; Duodenum; Electric Stimulation; Enzyme Inhibitors; Excitatory Postsynaptic Potentials; Guanethidine; Guinea Pigs; In Vitro Techniques; Male; Membrane Potentials; Muscle, Smooth; Neuromuscular Junction; Nitroarginine; Substance P; Synaptic Transmission | 1999 |